Last reviewed · How we verify
No antiplatelet treatment
No antiplatelet treatment is a Small molecule drug developed by Fundación Pública Andaluza para la gestión de la Investigación en Sevilla. It is currently in Phase 2 development.
At a glance
| Generic name | No antiplatelet treatment |
|---|---|
| Sponsor | Fundación Pública Andaluza para la gestión de la Investigación en Sevilla |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Assessment of the WATCHMAN™ Device in Patients Unsuitable for Oral Anticoagulation (NA)
- Tanhuo Decoction for Acute Coronary Syndrome With Cerebral Atherosclerosis in Elderly Patients (NA)
- REperfusion With P2Y12 Inhibitors in Addition to mEchanical thRombectomy for perFUsion Imaging Selected Acute Stroke patiEnts (PHASE3)
- EdoxabaN foR IntraCranial Hemorrhage Survivors With Atrial Fibrillation (ENRICH-AF) (PHASE4)
- Morphologic Evolution and Remodeling of Intracranial Atherosclerosis: A Longitudinal Study by 3D-rotational Angiography
- Adjuvant Clopidogrel in Staphylococcus Aureus Bacteremia (PHASE2)
- DAPT Strategy in HBR Patients Undergoing Complex PCI Following ACS: Second-Phase Beta Testing of a Patients Decision Aid (NA)
- Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO IV-EPIC 38) (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- No antiplatelet treatment CI brief — competitive landscape report
- No antiplatelet treatment updates RSS · CI watch RSS
- Fundación Pública Andaluza para la gestión de la Investigación en Sevilla portfolio CI
Frequently asked questions about No antiplatelet treatment
What is No antiplatelet treatment?
No antiplatelet treatment is a Small molecule drug developed by Fundación Pública Andaluza para la gestión de la Investigación en Sevilla.
Who makes No antiplatelet treatment?
No antiplatelet treatment is developed by Fundación Pública Andaluza para la gestión de la Investigación en Sevilla (see full Fundación Pública Andaluza para la gestión de la Investigación en Sevilla pipeline at /company/fundaci-n-p-blica-andaluza-para-la-gesti-n-de-la-investigaci-n-en-sevilla).
What development phase is No antiplatelet treatment in?
No antiplatelet treatment is in Phase 2.